2Borroni B, Pettenati C, Bordonali T, et al. Serum cholesterol levels modulate long-term efficacy of TCinesterase inhibitors in Alzheimer disease. Neurosci Lett, 2003, 343(2): 213.
3Tan ZS, Seshadri S, Beiser A, et al. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med, 2003,163(9) :1053.
4Kivipelto M, Helkala EL, Laakso MP,et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ, 2001,322(7300) :1447.
5Pappolla MA, Bryant-Thomas TK, Herbert D, et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology, 2003,61 (2): 199.
6Kivipelto M, Laakso MP, Tuomilehto J, et al. Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease:potential for pharmacological intervention. CNS Drugs, 2002,16(7 ) :435.
7Kuo YM, Emmerling MR, Bisgaier CL, et al. Elevated low-density lipoprotein in Alzheimer' s disease correlates with brain Aβ1-42 levels. Biochem Biophys Res Commun, 1998, 252(3): 711.
8Launer LJ, White LR, Petrovitch H, et al. Cholesterol and neuropathologic marhers of AD: a population-based autopsy study. Neurology,2001, 57(8): 1447.
9Refolo LM Pappolla MA, Malester B, et al. Hypercholesterolemia accelerates the Alzheimer' s amyloid pathology in a transgenic mouse model. Neurobiol Dis,2000, 7(4): 321.
10Lesser G, Kandiah K, Libow LS , et al. Elevated serum total and LDL cholesterol in very old patients with Alzheimer' s disease. Dement Geriatr Cogn Disord,2001, 12( 1 ): 138.
